Selected research
Industry Research
Meloxicam Drugs Industry Research Report 2026
Market perspective
The global Meloxicam Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Meloxicam Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Meloxicam Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Meloxicam Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Meloxicam Drugs include Boehringer Ingelheim, Iroko Pharmaceuticals, Lupin, Nipro, Novitium Pharma, Zydus, Jiangsu Jibeier Pharmaceutical, Kelun Pharmaceutical and Luye Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Meloxicam Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Meloxicam Drugs Market by Company
Boehringer Ingelheim
Iroko Pharmaceuticals
Lupin
Nipro
Novitium Pharma
Zydus
Jiangsu Jibeier Pharmaceutical
Kelun Pharmaceutical
Luye Pharma
Qilu Pharmaceutical
Simcere Pharmaceutical
Yangtze River Pharmaceutical
YaoPharma
Zhejiang Xianju Pharmaceutical
Meloxicam Drugs Segment by Type
Oral Preparations
Topical Preparations
Injections
Meloxicam Drugs Segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Meloxicam Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meloxicam Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Meloxicam Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meloxicam Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Meloxicam Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Meloxicam Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Meloxicam Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Preparations
- Topical Preparations
- Injections
Applications
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Companies covered
- Boehringer Ingelheim
- Iroko Pharmaceuticals
- Lupin
- Nipro
- Novitium Pharma
- Zydus
- Jiangsu Jibeier Pharmaceutical
- Kelun Pharmaceutical
- Luye Pharma
- Qilu Pharmaceutical
- Simcere Pharmaceutical
- Yangtze River Pharmaceutical
- YaoPharma
- Zhejiang Xianju Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Meloxicam Drugs Market Size (2021-2032)
- 2.2.2 Global Meloxicam Drugs Sales (2021-2032)
- 2.2.3 Global Meloxicam Drugs Market Average Price (2021-2032)
- 2.3 Meloxicam Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral Preparations
- 2.3.3 Topical Preparations
- 2.3.4 Injections
- 2.4 Meloxicam Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacy
- 2.4.3 Online Pharmacy
- 2.4.4 Retail Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Meloxicam Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Meloxicam Drugs Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Meloxicam Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Meloxicam Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Meloxicam Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Meloxicam Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Meloxicam Drugs, Product Type & Application
- 3.8 Global Manufacturers of Meloxicam Drugs, Established Date
- 3.9 Global Meloxicam Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Boehringer Ingelheim
- 4.1.1 Boehringer Ingelheim Company Information
- 4.1.2 Boehringer Ingelheim Business Overview
- 4.1.3 Boehringer Ingelheim Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Boehringer Ingelheim Meloxicam Drugs Product Portfolio
- 4.1.5 Boehringer Ingelheim Recent Developments
- 4.2 Iroko Pharmaceuticals
- 4.2.1 Iroko Pharmaceuticals Company Information
- 4.2.2 Iroko Pharmaceuticals Business Overview
- 4.2.3 Iroko Pharmaceuticals Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Iroko Pharmaceuticals Meloxicam Drugs Product Portfolio
- 4.2.5 Iroko Pharmaceuticals Recent Developments
- 4.3 Lupin
- 4.3.1 Lupin Company Information
- 4.3.2 Lupin Business Overview
- 4.3.3 Lupin Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Lupin Meloxicam Drugs Product Portfolio
- 4.3.5 Lupin Recent Developments
- 4.4 Nipro
- 4.4.1 Nipro Company Information
- 4.4.2 Nipro Business Overview
- 4.4.3 Nipro Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Nipro Meloxicam Drugs Product Portfolio
- 4.4.5 Nipro Recent Developments
- 4.5 Novitium Pharma
- 4.5.1 Novitium Pharma Company Information
- 4.5.2 Novitium Pharma Business Overview
- 4.5.3 Novitium Pharma Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Novitium Pharma Meloxicam Drugs Product Portfolio
- 4.5.5 Novitium Pharma Recent Developments
- 4.6 Zydus
- 4.6.1 Zydus Company Information
- 4.6.2 Zydus Business Overview
- 4.6.3 Zydus Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Zydus Meloxicam Drugs Product Portfolio
- 4.6.5 Zydus Recent Developments
- 4.7 Jiangsu Jibeier Pharmaceutical
- 4.7.1 Jiangsu Jibeier Pharmaceutical Company Information
- 4.7.2 Jiangsu Jibeier Pharmaceutical Business Overview
- 4.7.3 Jiangsu Jibeier Pharmaceutical Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Jiangsu Jibeier Pharmaceutical Meloxicam Drugs Product Portfolio
- 4.7.5 Jiangsu Jibeier Pharmaceutical Recent Developments
- 4.8 Kelun Pharmaceutical
- 4.8.1 Kelun Pharmaceutical Company Information
- 4.8.2 Kelun Pharmaceutical Business Overview
- 4.8.3 Kelun Pharmaceutical Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Kelun Pharmaceutical Meloxicam Drugs Product Portfolio
- 4.8.5 Kelun Pharmaceutical Recent Developments
- 4.9 Luye Pharma
- 4.9.1 Luye Pharma Company Information
- 4.9.2 Luye Pharma Business Overview
- 4.9.3 Luye Pharma Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Luye Pharma Meloxicam Drugs Product Portfolio
- 4.9.5 Luye Pharma Recent Developments
- 4.10 Qilu Pharmaceutical
- 4.10.1 Qilu Pharmaceutical Company Information
- 4.10.2 Qilu Pharmaceutical Business Overview
- 4.10.3 Qilu Pharmaceutical Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Qilu Pharmaceutical Meloxicam Drugs Product Portfolio
- 4.10.5 Qilu Pharmaceutical Recent Developments
- 4.11 Simcere Pharmaceutical
- 4.11.1 Simcere Pharmaceutical Company Information
- 4.11.2 Simcere Pharmaceutical Business Overview
- 4.11.3 Simcere Pharmaceutical Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Simcere Pharmaceutical Meloxicam Drugs Product Portfolio
- 4.11.5 Simcere Pharmaceutical Recent Developments
- 4.12 Yangtze River Pharmaceutical
- 4.12.1 Yangtze River Pharmaceutical Company Information
- 4.12.2 Yangtze River Pharmaceutical Business Overview
- 4.12.3 Yangtze River Pharmaceutical Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Yangtze River Pharmaceutical Meloxicam Drugs Product Portfolio
- 4.12.5 Yangtze River Pharmaceutical Recent Developments
- 4.13 YaoPharma
- 4.13.1 YaoPharma Company Information
- 4.13.2 YaoPharma Business Overview
- 4.13.3 YaoPharma Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 YaoPharma Meloxicam Drugs Product Portfolio
- 4.13.5 YaoPharma Recent Developments
- 4.14 Zhejiang Xianju Pharmaceutical
- 4.14.1 Zhejiang Xianju Pharmaceutical Company Information
- 4.14.2 Zhejiang Xianju Pharmaceutical Business Overview
- 4.14.3 Zhejiang Xianju Pharmaceutical Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Zhejiang Xianju Pharmaceutical Meloxicam Drugs Product Portfolio
- 4.14.5 Zhejiang Xianju Pharmaceutical Recent Developments
5 Global Meloxicam Drugs Market Scenario by Region
- 5.1 Global Meloxicam Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Meloxicam Drugs Sales by Region: 2021-2032
- 5.2.1 Global Meloxicam Drugs Sales by Region: 2021-2026
- 5.2.2 Global Meloxicam Drugs Sales by Region: 2027-2032
- 5.3 Global Meloxicam Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Meloxicam Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Meloxicam Drugs Revenue by Region: 2027-2032
- 5.4 North America Meloxicam Drugs Market Facts & Figures by Country
- 5.4.1 North America Meloxicam Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Meloxicam Drugs Sales by Country (2021-2032)
- 5.4.3 North America Meloxicam Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Meloxicam Drugs Market Facts & Figures by Country
- 5.5.1 Europe Meloxicam Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Meloxicam Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Meloxicam Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Meloxicam Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Meloxicam Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Meloxicam Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Meloxicam Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Meloxicam Drugs Market Facts & Figures by Country
- 5.7.1 South America Meloxicam Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Meloxicam Drugs Sales by Country (2021-2032)
- 5.7.3 South America Meloxicam Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Meloxicam Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Meloxicam Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Meloxicam Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Meloxicam Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Meloxicam Drugs Sales by Type (2021-2032)
- 6.1.1 Global Meloxicam Drugs Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Meloxicam Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Meloxicam Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Meloxicam Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Meloxicam Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Meloxicam Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Meloxicam Drugs Sales by Application (2021-2032)
- 7.1.1 Global Meloxicam Drugs Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Meloxicam Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Meloxicam Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Meloxicam Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Meloxicam Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Meloxicam Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Meloxicam Drugs Value Chain Analysis
- 8.1.1 Meloxicam Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Meloxicam Drugs Production Mode & Process
- 8.2 Meloxicam Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Meloxicam Drugs Distributors
- 8.2.3 Meloxicam Drugs Customers
9 Global Meloxicam Drugs Analyzing Market Dynamics
- 9.1 Meloxicam Drugs Industry Trends
- 9.2 Meloxicam Drugs Industry Drivers
- 9.3 Meloxicam Drugs Industry Opportunities and Challenges
- 9.4 Meloxicam Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst